Log In
person
Illumina Inc
ILMN
summarize
4 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Core Illumina |
Genetic, Genomic, and Sequencing Equipment for Life Science Research
These companies manufacture life science research equipment such as genetic, genomic, and sequencing equipment for pharmaceutical manufacturers and sell directly to their customers.
|
3.11B | 68.55% |
| Core Illumina |
Research Equipment for Drug Manufacturers
These companies manufacture pharamaceutical and biotech research research equipment for drug manufacturers and sell directly to their customers.
|
0.71B | 15.58% |
| Core Illumina |
Genetic, Genomic, and Sequencing Services for Life Science Research
These companies provide genetic, genomic, and sequencing services for life science research.
|
0.63B | 13.82% |
| GRAIL |
Genetic, Genomic, and Sequencing Medical Diagnostic Services; Private Insurance
These companies operate genetic diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. The majority of revenue is ultimately derived from commercial insurance providers.
|
0.09B | 2.05% |
| keyboard_arrow_down |
Core Illumina
Genetic, Genomic, and Sequencing Equipment for Life Science Research
|
3.11B | 68.55% |
| keyboard_arrow_right |
These companies manufacture life science research equipment such as genetic, genomic, and sequencing equipment for pharmaceutical manufacturers and sell directly to their customers.
|
||
| keyboard_arrow_down |
Core Illumina
Research Equipment for Drug Manufacturers
|
0.71B | 15.58% |
| keyboard_arrow_right |
These companies manufacture pharamaceutical and biotech research research equipment for drug manufacturers and sell directly to their customers.
|
||
| keyboard_arrow_down |
Core Illumina
Genetic, Genomic, and Sequencing Services for Life Science Research
|
0.63B | 13.82% |
| keyboard_arrow_right |
These companies provide genetic, genomic, and sequencing services for life science research.
|
||
| keyboard_arrow_down |
GRAIL
Genetic, Genomic, and Sequencing Medical Diagnostic Services; Private Insurance
|
0.09B | 2.05% |
| keyboard_arrow_right |
These companies operate genetic diagnostic labs. Medical service professionals order diagnostic tests for patients, but the diagnostic services firms bill either the patient directly or through the patient''s insurance provider. The majority of revenue is ultimately derived from commercial insurance providers.
|
||